Abstract

Antimicrobial resistance (AMR) in Campylobacter spp. (Campylobacter coli and Campylobacter jejuni) is a concern due to its importance in public health, particularly when it involves aminoglycosides and macrolides, drugs of choice for treatment of human cases. Co-resistance to these two antimicrobial classes involves transfer of genetic elements and/or acquisition of mutations in different genetic loci, which can in turn spread through vertical or horizontal gene transfer (HGT) phenomena, with each route having different potential implications. This study aimed at evaluating the association between the presence of phenotypic resistance to these two antimicrobial classes in C. coli and C. jejuni recovered from livestock at slaughterhouses in Spain (as part of the AMR surveillance program), and at assessing the genetic heterogeneity between resistant and susceptible isolates by analysing the “short variable region” (SVR) of the flaA gene. Over the 2002–2018 period, antimicrobial susceptibility test results from 10,965 Campylobacter isolates retrieved from fecal samples of broilers, turkeys, pigs and cattle were collected to compare the proportion of resistant isolates and the Minimum Inhibitory Concentrations (MICs) against six antimicrobials including gentamicin (GEN), streptomycin (STR), and erythromycin (ERY). AMR-associated genes were determined for a group of 51 isolates subjected to whole genome sequencing, and the flaA SVR of a subset of 168 isolates from all hosts with different resistotypes was used to build a Neighbor-Joining-based phylogenetic tree and assess the existence of groups by means of “relative synonymous codon usage” (RSCU) analysis. The proportion of antimicrobial resistant isolates to both, aminoglycosides and macrolides, varied widely for C. coli (7–91%) and less for C. jejuni (all hosts 0–11%). Across hosts, these proportions were 7–56% in poultry, 12–82% in cattle, and 22–91% in pigs for C. coli and 0–8% in poultry and 1–11% in cattle for C. jejuni. Comparison of the MIC distributions revealed significant host-specific differences only for ERY in C. jejuni (p = 0.032). A significant association in the simultaneous presentation of AMR to both antimicrobial classes was observed across hosts/bacterial species. The flaA gene analysis showed clustering of isolates sharing resistotype and to a lesser degree bacterial species and host. Several resistance markers associated with resistance to aminoglycosides and macrolides were found among the sequenced isolates. The consistent association between the simultaneous presentation of AMR to aminoglycosides and macrolides in all hosts could be due to the persistence of strains and/or resistance mechanisms in Campylobacter populations in livestock over time. Further studies based on whole genome sequencing are needed to assess the epidemiological links between hosts and bacterial strains.

Highlights

  • Campylobacter coli and Campylobacter jejuni, thermophilic bacteria of the genus Campylobacter spp., are the most frequently notified human gastrointestinal zoonotic pathogens in the European Union (EU) since 2005 (EFSA, 2005, 2006, 2007)

  • There were differences depending on the year, the proportion of positive samples to C. coli and C. jejuni remained relatively constant over the whole study period in pigs and cattle, with one bacterial species being more prevalent than the other one, while the situation was more variable in broilers (Figure 1)

  • It is of paramount importance to explore the genetic mechanisms implicated in antimicrobial resistance (AMR) in C. coli and C. jejuni from the different hosts involved in the epidemiology of infection in humans (EFSA-ECDC, 2020)

Read more

Summary

Introduction

Campylobacter coli and Campylobacter jejuni, thermophilic bacteria of the genus Campylobacter spp., are the most frequently notified human gastrointestinal zoonotic pathogens in the European Union (EU) since 2005 (EFSA, 2005, 2006, 2007). Macrolides [erythromycin (ERY) and azithromycin] and fluoroquinolones [ciprofloxacin (CIP)] are the drugs of choice in human patients requiring antibiotic treatment, but the latter class is not recommended for children When these drugs are ineffective, systemic administration of aminoglycosides is the only option left (Bolinger and Kathariou, 2017; World Health Organization (WHO), 2017). Levels of AMR to aminoglycosides and macrolides in clinical thermophilic Campylobacter from humans are increasing (Aarestrup and Wegener, 1999; Bolinger and Kathariou, 2017; EFSA-ECDC, 2019b), and a similar trend for macrolides has been observed in isolates from pigs and broilers (Moore et al, 2006; Wang et al, 2016). C. coli is as prevalent as C. jejuni in broilers in some countries (Wieczorek and Osek, 2013), monitoring of C. coli and C. jejuni AMR levels, to macrolides and aminoglycosides, is important (EFSA-ECDC, 2018a, 2019b)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call